CDK1 and hepatocellular carcinoma: In terms of these top 20 GO terms (Figure 6A–6C), CXP treatment of HCC mainly involves the regulation of “response to oxygen-containing compound (GO:1901700)”, “response to lipid (GO:0033993)”, “cellular response to chemical stimulus (GO:0070887)”, “heme binding (GO:0020037)”, “tetrapyrrole binding (GO:0046906)”, “estrogen 2-hydroxylase activity (GO:0101021)”, “cyclin B1-CDK1 complex (GO:0097125)”, “endoplasmic reticulum (GO:0005783)”, and “cytoplasmic part (GO:0044444)”, among others.